Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1low mouse model of the disease

Experimental Hematology

Volumn 36, Issue 2, 2008, Pages 158-171

  Migliaccio, Anna Rita ^a,d   Martelli, Fabrizio ^a,d   Verrucci, Maria ^a   Migliaccio, Giovanni ^a   Vannucchi, Alessandro Maria ^b   Ni, Hongyu ^c   Xu, Mingjiang ^d   Jiang, Yi ^e   Nakamoto, Betty ^e   Papayannopoulou, Thalia ^e   Hoffman, Ronald ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR GATA 1;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; MOUSE; MYELOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

AGE FACTORS; ANIMALS; BONE MARROW; CELL MOVEMENT; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, MUTANT STRAINS; MYELOFIBROSIS; ORGAN SPECIFICITY; RECEPTORS, CXCR4; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; MUS;

EID: 38349018496     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.10.001     Document Type: Article

References (66)

1. Hoffman R., Xu M., and Barosi G. Myelofibrosis with myeloid metaplasia. In: Hoffman R., Benz Jr. E., Shattil S., et al. (Eds). Hematology: Basic Principles and Practice. 5th ed. (2008), Churchill Livingstone, New York In press
2. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 342 (2000) 1255-1265
3. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17 (1999) 2954-2970
4. Guyot B., Murai K., Fujiara Y., et al. Characterization of a megakaryocyte-specific enhancer of the key hemopoietic transcription factor GATA-1. J Biol Chem 281 (2006) 13733-13742
5. McDevitt M.A., Shivdasani R.A., Fujiwara Y., Yang H., and Orkin S.H. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A 94 (1997) 6781-6785
6. Vyas P., Ault K., Jackson C.W., Orkin S.H., and Shivdasani R.A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93 (1999) 2867-2875
7. Centurione L., Di Baldassarre A., Zingariello M., et al. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 104 (2004) 3573-3580
8. Schmitt A., Jouault H., Guichard J., Wendling F., Drouin A., and Cramer E.M. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96 (2000) 1342-1347
9. Thiele J., Lorenzen J., Manich B., et al. Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol 97 (1997) 137-143
10. low mice). Blood 100 (2002) 1123-1132
11. low mutation in mice of different genetic backgrounds. Blood 106 (2005) 4102-4113
12. Vannucchi A.M., Bianchi L., Paoletti F., et al. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Blood 105 (2005) 3493-3501
13. Terui T., Niitsu Y., Mahara K., et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75 (1990) 1540-1548
14. Le Bousse-Kerdilès M.C., Chevillard S., Charpentier A., et al. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88 (1996) 4534-4546
15. Xu M., Bruno E., Chao J., et al. The constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 105 (2005) 4508-4515
16. Kim C.H., and Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91 (1998) 100-110
17. Mcgrath K.E., Koniski A.D., Maltby K.M., McGann J.K., and Palis J. Embrionic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 213 (1999) 442-456
18. Lapidot T., and Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30 (2002) 973-981
19. Papayannopoulou T. Bone marrow homing: the players, the playfield, and their evolving roles. Curr Opin Hematol 10 (2003) 214-219
20. Taichman R.S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem cell niche. Blood 105 (2005) 2631-2639
21. Taichman R.S., and Emerson S.G. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16 (1998) 7-15
22. Calvi L.M., Adams G.B., Welbrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
23. Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W., and Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91 (1998) 4523-4530
24. Zou Y.-R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599
25. Ara T., Tokoyoda K., Sugiyama T., Egawa T., Kawabata K., and Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 19 (2003) 257-267
26. Sugiyama T., Kohara H., Noda M., and Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCR12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25 (2006) 977-988
27. McQuibban G.A., Butler G.S., Gong J.H., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276 (2001) 43503-43508
28. Sadir R., Imberty A., Baleux F., and Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 279 (2004) 43854-43860
29. Delgado M.B., Clark-Lewis I., Loetscher P., et al. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol 31 (2001) 699-707
30. Valenzuela-Fernandez A., Planchenault T., Baleux F., et al. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 277 (2002) 15677-15689
31. Lane W.J., Dias S., Hattori K., et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96 (2000) 4152-4159
32. Hodohara K., Fujii N., Yamamoto N., and Kaushansky K. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 95 (2000) 769-775
33. Dar A., Goicheberg P., Shinder V., et al. Chemochine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 6 (2005) 1038-1046
34. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
35. Perez L.E., Alpdogan O., Shieh J.H., et al. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp Hematol 32 (2004) 300-307
36. Lapidot T., and Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 16 (2002) 1992-2003
37. Pelus L.M., Bian H., Fukuda S., Wong D., Merzouk A., and Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp Hematol 33 (2005) 295-307
38. Broxmeyer H., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
39. Sweeney E.A., Lortat-Jacob H., Priestley G.V., Nakamoto B., and Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 99 (2002) 44-51
40. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
41. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 110 (2003) 187-196
42. Lévesque J.P., Hendy J., Takamatsu Y., Williams B., Winkler I.G., and Simmons P.J. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30 (2002) 440-449
43. Ponomaryov T., Peled A., Petit I., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106 (2000) 1331-1339
44. Sanchez M., Weissman I.L., Valeri M., et al. Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress. Stem Cells 24 (2006) 337-347
45. low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 109 (2007) 1460-1471
46. Ni H., Barosi G., Rondelli D., and Hoffman R. Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis. Am J Clin Pathol 123 (2005) 833-839
47. Devine S.M., Hoffman R., Verma A., et al. Allogenic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 99 (2002) 2255-2258
48. Mitruka B.M., and Rawnsley H.M. Clinical, Biochemical and Hematological Reference Values in Normal Experimental Animals and Normal Humans (1981), Masson Publishing, New York p. 413
49. Harkness J.E., and Wagner J.E. Biology and husbandry. In: Harkness J.E., and Wagner J.E. (Eds). The Biology and Medicine of Rabbits and Rodents. 3rd ed. (1989), Lea & Febiger, Philadelphia 372
50. van de Rijn M., Heimfeld S., Spangrude G.J., and Weissman I.L. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A 86 (1989) 4634-4638
51. Akashi K., Traver D., Miyamoto T., and Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 (2000) 193-197
52. Na Nakorn T., Traver D., Weissman I.L., and Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 109 (2002) 1579-1585
53. Bonig H., Priestley G.V., Oheler V., and Papayannopoulou T. Hematopoietic progenitor cells (HPC) form mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 35 (2007) 326-334
54. Kawabata K., Ujikawa M., Egawa T., et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A 96 (1999) 5663-5667
55. Lataillade J.J., Clay D., Bourin P., et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99 (2002) 1117-1129
56. Ciurea S.O., Merchant D., Mahmud N., et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 110 (2007) 986-993
57. Kacena M.A., Shivdasani R.A., Wilson K., et al. Megakaryocyte-Osteoblast Interaction Revealed in Mice Deficient in Transcription Factors GATA-1 and NF-E2. J Bone Miner Res 19 (2004) 652-660
58. De La Luz Sierra M., Yang F., Narazaki M., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103 (2004) 2452-2459
59. Rosti V., Massa M., Vannucchi A.M., et al. The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia. Blood Cells Mol Dis 38 (2007) 280-286
60. Shi J., Ishii T., Hu T., et al. Effects of chromatin modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. Cancer Res 67 (2007) 6417-6424
61. Guglielmelli P., Zini R., Bogani C., et al. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells 25 (2007) 165-173
62. Baxter E.J., Scott L.M., Campbell P.J., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Cancer Genome Project. Lancet 365 (2005) 1054-1061
63. Levine R.L., Wadleigh M., Cools J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387-397
64. James C., Ugo V., Le Couedic J.P., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
65. Geay J.F., Buet D., Zhang Y., et al. p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression. Cancer Res 65 (2005) 2676-2683
66. Peled A., Hardan I., Trakhtenbrot L., et al. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Stem Cells 20 (2002) 259-266